A clinical trial to study the effect of Triphala,Musta,Chitraka Ghana capsules in Prediabetes in Overweight subjects.

"A Randomized,Double Blind, Controlled Clinical Study Of Triphala,Musta,Chitraka Ghana Capsules In Insulin Resistance In Overweight Subjects With Special Referance To Sthaulya" - RACT

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025997

Enrollment

Registered

2020-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Triphala,Musta,Chitraka Ghana capsules : Triphala,Musta,Chitraka Ghana capsules 750mg-4 capsules twice a day before meal for 30 days Control Intervention1: Placebo with dietary modifica

Eligibility

Inclusion criteria

Inclusion criteria: HOMA IR:HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE-METHOD FOR ASSESSING B-CELL FUNCTION AND INSULIN RESISTANCE(IR)FROM BASAL(FASTING)GLUCOSE AND INSULIN OR C-PEPTIDE CONCENTRATION. BMI >25

Exclusion criteria

Exclusion criteria: Sujects who are under OHA/Steroids/Lipid Lowering Agents Pregnant or Lactating woman Patients with Chronic Alcoholism

Design outcomes

Primary

Measure	Time frame
Reduction In HOMA-IRTimepoint: In 30 Days	—

Secondary

Measure	Time frame
Reduction in BMI,Ama Lakshana,Sthaulya LakshanaTimepoint: In 30 Days	—

Countries

India

Contacts

Public ContactVd Vishwas Gogate

Government Ayurved College,Nanded

vishwas_eknath@yahoo.co.in9422214311

Outcome results